| Trial ID: | L6364 |
| Source ID: | NCT00690287
|
| Associated Drug: |
Azd6370
|
| Title: |
A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: AZD6370|DRUG: AZD6370|DRUG: Placebo
|
| Outcome Measures: |
Primary: Pharmacodynamic variables, Blood samples taken repeatedly during 24 hours on study day sessions | Secondary: Safety variables, Blood samples taken repeatedly during 24 hours on study day sessions|Pharmacokinetic variables, Blood samples taken repeatedly during 24 hours on study day sessions
|
| Sponsor/Collaborators: |
Sponsor: AstraZeneca
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-02
|
| Completion Date: |
2008-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-01-11
|
| Locations: |
Research Site, Linköping, Sweden|Research Site, Luleå, Sweden|Research Site, Uppsala, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT00690287
|
